Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
3.150
+0.080 (2.61%)
At close: Oct 8, 2025, 4:00 PM EDT
3.220
+0.070 (2.22%)
After-hours: Oct 8, 2025, 4:23 PM EDT
Annexon Market Cap
Annexon has a market cap or net worth of $346.14 million as of October 8, 2025. Its market cap has decreased by -53.40% in one year.
Market Cap
346.14M
Enterprise Value
150.05M
1-Year Change
-53.40%
Ranking
Category
Stock Price
$3.15
Market Cap Chart
Since July 24, 2020, Annexon's market cap has decreased from $639.51M to $346.14M, a decrease of -45.87%. That is a compound annual growth rate of -11.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 337.35M | -38.31% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | 955.09M | 49.35% |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 761.01B |
| Johnson & Johnson | 452.55B |
| AbbVie | 403.16B |
| UnitedHealth Group | 325.81B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 233.06B |